Each year, the National Drug and Alcohol Research Center at UNSW Sydney surveys hundreds of people who regularly use drugs in ...

A team from the Wistar Institute has demonstrated the role of Parkin—a protein implicated in Parkinson's disease—in the ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

The study said that identifiable local field potential signals, strong enough to be used for triggering therapy, were found ...

But some 80 percent of people with Parkinson's disease have GI problems, such as acid reflux, irritable bowel syndrome, and constipation, which often emerge decades before motor difficulties do. This ...

THURSDAY, Sept. 11, 2024 (HealthDay News) -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab ...

Researchers at Karolinska Institutet have identified a mechanism responsible for a serious psychiatric complication caused by ...

Two groundbreaking studies from UC San Francisco (UCSF) are bringing the promise of round-the-clock personalized care for ...

BOSTON - A new study finds Parkinson's disease may begin in the gut. Scientists have been interested in this possible link for some time.

Sun Pharma and Israel-based Moebius Medical on Friday said that USFDA has granted fast track designation to novel non-opioid therapy MM-II against osteoarthritis knee pain. USFDA fast track ...

A recent study by scientists from Queen Mary University of London has revealed something unexpected about Parkinson’s disease. They discovered that certain medications commonly used to treat ...

The news keeps getting better for the new GLP-1 weight-loss drugs fromEli Lilly and Novo Nordisk.